LFMDLifeMD, Inc.

$200M

Q4 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$13M+226.9% YoY

Gross Profit

$9M69.1% margin

Operating Income

-$32M-250.7% margin

Net Income

-$32M-250.1% margin

EPS (Diluted)

$-2.56

QoQ Revenue Growth

+17.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$13M

Total Liabilities

$14M

Stockholders' Equity

$1M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$4M	+226.9%
Gross Profit	$9M	$3M	+159.5%
Operating Income	-$32M	-$519,368	-6124.5%
Net Income	-$32M	-$711,547	-4432.5%

Revenue Segments

Product Revenues, Net

$20M88%

Software Revenues, Net

$3M12%

LFMD Q4 2020 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena